Atlas Antibodies AB

6 articles about Atlas Antibodies AB

• T-Cure Bioscience, Inc. and Atlas Antibodies AB Enter a Collaboration Agreement for the Development, Manufacture, and Supply of CT83 (KK-LC-1) Monoclonal Antibodies

  10/5/2021

  T-Cure Bioscience, Inc. and Atlas Antibodies AB , a Swedish company commercializing PrecisA monoclonal antibodies (mAb) for oncology targets, announced today a collaborative agreement for the development, manufacture, and supply of CT83 (KK-LC-1) mAb.

• Atlas Antibodies acquires HistoCyte Laboratories, a global leader in cell line controls for histopathology

  2/16/2021

  Atlas Antibodies AB has signed an agreement to acquire UK company HistoCyte Laboratories Ltd. HistoCyte Laboratories' portfolio of innovative cell line materials provides control of immunohistochemical assays used in the diagnosis of cancers.

• Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins Using Mass Spectrometry

  9/16/2019

  Atlas Antibodies AB announced the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography–mass spectrometry.

• Sigma-Aldrich Corporation and Atlas Antibodies AB Announce 2,300 New, Highly Validated Prestige Antibodies(RM)

  6/24/2009

• Sigma-Aldrich Corporation And Atlas Antibodies AB Announce 2,300 New, Highly Validated Prestige Antibodies

  6/23/2009

• Sigma-Aldrich Corporation and Atlas Antibodies AB Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies

  8/20/2008